Results 61 to 70 of about 10,321,160 (239)
NIAMI: Towards the optimization of results in primary PCI
The NAIMI trial has recently been published. It assessed one of the most contemporary and challenging issues in the management of acute myocardial infarction (AMI), namely prevention of reperfusion injury (RPI) after primary PCI for ST-elevation myocardial infarction (STEMI).
Gehani, Abdurrazzak +2 more
openaire +2 more sources
Primary PCI in ST-elevation myocardial infarction: Mode of referral and time to PCI
According to the current guidelines for treatment of ST-elevation myocardial infarction (STEMI), percutaneous coronary intervention (PCI) should be performed within 90 min of first medical contact and total ischemic time should not exceed 120 min. The aim of this study was to analyze compliance with STEMI guidelines in a tertiary PCI center.This was a ...
Pedro, Jerónimo Sousa +11 more
openaire +2 more sources
Background: The benefits of Primary percutaneous coronary intervention (PCI) for ST elevation myocardial infarction (STEMI) have been demon-strated, but most studies were conducted in experienced centres in western world.
doaj +1 more source
Complete Versus Lesion-Only Primary PCI
Background Complete revascularization may improve outcomes compared with an infarct-related artery (IRA)-only strategy in patients being treated with primary percutaneous coronary intervention (PPCI) who have multivessel disease presenting with ST ...
G. Mccann +15 more
semanticscholar +1 more source
The Broad Spectrum HDAC Inhibitor PCI-24781 Induces Caspase- and ROS-Dependent Apoptosis and is Synergistic with Bortezomib in Lymphoma [PDF]
We investigated the cytotoxicity and biology of the novel broad-spectrum hydroxamic acid-based histone deacetylase inhibitor (HDACi), PCI-24781. PCI-24781 was studied alone and combined with bortezomib in Hodgkin lymphoma (L428) and non-Hodgkin's ...
Kevin David +9 more
core
Introduction Primary percutaneous coronary intervention (P-PCI) is still preferred as the optimal reperfusion therapy among patients with ST-segment elevation myocardial infarction (STEMI).
Mohammed Habib, Zaki Doğan
doaj +1 more source
Rajesh Kumar,1 Mahesh Kumar Batra,1 Sanam Khowaja,1 Ali Ammar,1 Ashok Kumar,1 Jehangir Ali Shah,1 Jawaid Akbar Sial,1 Tahir Saghir,1 Musa Karim2 1Adult Cardiology Department, National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan ...
Kumar R +8 more
doaj
Correlation of Admission Level of Galectin-3 and Cardiac Remodeling after Primary Percutaneous Coronary Intervention [PDF]
Background: Galectin-3, a biomarker associated with cardiac remodeling, has been linked to poor outcomes in patients with acute STEMI. Understanding its predictive capacity after primary percutaneous coronary intervention [PPCI] is critical for improving
Hussein Hassan +3 more
doaj +1 more source
Enhancing the efficacy of cytotoxic agents for cancer therapy using photochemical internalisation. [PDF]
Photochemical internalisation (PCI) is a technique for improving cellular delivery of certain bioactive agents which are prone to sequestration within endolysosomes.
Martinez de Pinillos Bayona, A +9 more
core +1 more source
Aim. To study prognostic significance of coronary atherosclerosisseverity (residual SYNTAX) after primary percutaneous intervention (PCI) in myocardial infarction patients with STE (STEMI) and multivessel coronary lesion, in long term period.Material and
R. S. Tarasov +4 more
doaj +1 more source

